{"id":106148,"date":"2021-06-10T22:11:06","date_gmt":"2021-06-10T14:11:06","guid":{"rendered":"https:\/\/www.mediaintel.asia\/?p=413632"},"modified":"2021-06-10T22:11:06","modified_gmt":"2021-06-10T14:11:06","slug":"taiwan-says-astrazeneca-covid-shot-production-talks-fell-through-4","status":"publish","type":"post","link":"https:\/\/www.chinalegalblog.com\/en\/2021\/06\/10\/taiwan-says-astrazeneca-covid-shot-production-talks-fell-through-4\/","title":{"rendered":"Taiwan says AstraZeneca COVID shot production talks fell through"},"content":{"rendered":"<div align=\"center\"><a href=\"https:\/\/www.mediaintel.asia\/\" title=\"MediaIntel.Asia provides Media Intelligence and Media Monitoring in Asia\" ><img src=\"https:\/\/www.mediaintel.asia\/wp-content\/uploads\/mediaintelasia-logo-blackyellow-400x300-1.png\" border=\"0\" width=\"200\" height=\"150\" alt=\"MediaIntel.Asia\"><\/a><\/div>\n<p>Taiwan says AstraZeneca COVID shot production talks fell through By Syndicated Content Jun 10, 2021 &#124; 6:20 AM<br \/>\nTAIPEI (Reuters) \u2013 Taiwan discussed with AstraZeneca Plc producing its COVID-19 vaccine but the talks fell through as the government felt it could not produce the 300 million shots the company requested, Health Minister Chen Shih-chung said on Thursday.<br \/>\nTaiwan has been striving to speed up deliveries of 20 million vaccine doses it has ordered from overseas, including from AstraZeneca and Moderna Inc, as it battles a spike in domestic infections.<br \/>\nOnly around 3% of Taiwan\u2019s 23.5 million people have received at least one shot so far, with further supplies held up by global production problems.<br \/>\nTaking lawmaker questions in parliament, Chen said the government had talked with AstraZeneca about producing 100 million doses on the firm\u2019s behalf, but the company had said it had hoped for a minimum of 300 million doses.<br \/>\n\u201cWe considered that it would be difficult, and would fully occupy production lines. It\u2019s not possible for Taiwan to consume so much,\u201d he said.<br \/>\nAstraZeneca declined to comment.<br \/>\nChen said on Tuesday that production problems at AstraZeneca\u2019s Thailand plant would delay deliveries.<br \/>\nOn Saturday, he said Taiwan was in talks with U.S. companies about making their COVID-19 vaccines, though he did not name them.<br \/>\nTaiwan has also ordered 10 million domestically developed vaccines from two local firms.<br \/>\n(Reporting by Ben Blanchard; Editing by Stephen Coates and Peter Graff)<\/p>\n<p>This data comes from <a href=\"https:\/\/www.mediaintel.asia\/\" title=\"MediaIntel.Asia provides Media Intelligence and Media Monitoring in Asia\" >MediaIntel.Asia's Media Intelligence and Media Monitoring Platform<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Taiwan says AstraZeneca COVID shot production talks fell through By Syndicated Content Jun 10, 2021 &#124; 6:20 AM<br \/>\nTAIPEI (Reuters) \u2013 Taiwan discussed with AstraZeneca Plc producing its COVID-19 vaccine but the talks fell through as the government fel&#8230;<\/p>\n","protected":false},"author":253,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[288,194,64],"tags":[10424,10324,2492,1745,7035],"class_list":["post-106148","post","type-post","status-publish","format-standard","hentry","category-medicine","category-news-chinese-law","category-taiwan","tag-china-general-news","tag-covid-19","tag-taipei","tag-thailand","tag-vaccine"],"_links":{"self":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/106148"}],"collection":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/users\/253"}],"replies":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/comments?post=106148"}],"version-history":[{"count":1,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/106148\/revisions"}],"predecessor-version":[{"id":106149,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/106148\/revisions\/106149"}],"wp:attachment":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/media?parent=106148"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/categories?post=106148"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/tags?post=106148"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}